Article: Protease inhibitors: no knockout blow, but could be the best punch yet.

With recent approval of two protease inhibitors -- and a third on the way -- AIDS clinicians and patients face a new era of treatment that brings both excitement and confusion. While researchers are touting protease inhibitors as the best news in AIDS treatment since AZT, they caution against unrealistic expectations and uninformed decisions.

Excitement over recent trial results of three protease inhibitors, as well as concerns about resistance, cost, and side effects, were recently discussed by a panel of experts during an interactive forum sponsored by community AIDS organizations around the country. Televised in late February in a dozen cities, the Washington, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!